MDCPartners specializes in business intelligence and strategic consultancy for clinical trial optimization, medical expert identification and regulatory affairs. We combine drug development expertise and unique IT architecture to provide cost effective solutions to the pharmaceutical and medical device industry. MDCPartners applies the principles of semantic web mining to address pharma business intelligence challenges posed by an expanding complex data offering driven by transparency in drug development and healthcare. Our flagship product ta-Scan is fast becoming the industry standard for clinical research planning and operations. The platform enables a prevailing snapshot on any therapeutic area, revealing data relationships between drugs, trials, patient populations and researchers. MDCPartners has been acquired by the Anju Software Group in June 2018. Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. Anju provides an integrated intelligence platform, supporting clinical operations and medical affairs. Learn more about us: mdcpartners.be https://anjusoftware.com/ Learn more about our products: ta-Scan - clinical business intelligence: ta-scan.com normScan - monitoring and tracking for medical device standards: normscan.com Follow us on our other social media: Twitter: twitter.com/MDC_Partners Vimeo: vimeo.com/mdcp